Jove
Visualize
联系我们

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Enhancing missense variant pathogenicity prediction with protein language models using VariPred.

Scientific reports·2024
Same author

Do antibody CDR loops change conformation upon binding?

mAbs·2024
Same author

abYpap: improvements to the prediction of antibody VH/VL packing using gradient boosted regression.

Protein engineering, design & selection : PEDS·2023
Same author

Antibody markup language (AbML) - a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw).

mAbs·2022
Same author

GraphQL for the delivery of bioinformatics web APIs and application to ZincBind.

Bioinformatics advances·2022
Same author

Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics.

mAbs·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: May 24, 2025

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.8K

一个利用蛋白质语言模型的抗体开发能力分类管道.

James Sweet-Jones1, Andrew C R Martin1

  • 1Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, UK.

mAbs
|March 5, 2025
PubMed
概括
此摘要是机器生成的。

这项研究引入了一种机器学习管道,以识别具有有利可开发性特征的治疗单克隆抗体 (mAbs). 该方法使用蛋白质语言模型在发育早期选择有前途的抗体候选者,降低成本并提高成功率.

关键词:
抗体是一种抗体.开发能力 开发能力机器学习是机器学习.预测 预测 预测 预测蛋白质语言模型的模型

更多相关视频

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.5K
Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins
08:46

Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins

Published on: September 22, 2020

3.7K

相关实验视频

Last Updated: May 24, 2025

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.8K
Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.5K
Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins
08:46

Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins

Published on: September 22, 2020

3.7K

科学领域:

  • 生物技术是生物技术.
  • 免疫学 免疫学 免疫学
  • 计算生物学 计算生物学

背景情况:

  • 治疗性单克隆抗体 (mAbs) 是一种关键的生物药物类别.
  • 虽然结合亲和力至关重要,但抗体序列和结构显著影响开发能力和临床成功.
  • 由于开发能力不佳而导致的晚期故障是常见的和昂贵的.

研究的目的:

  • 从大型图书馆中开发可开发抗体候选人的计算管道.
  • 利用机器学习和蛋白质语言模型进行早期抗体查.
  • 为了降低治疗抗体开发的成本和提高效率.

主要方法:

  • 利用配对的人类抗体序列数据.
  • 开发了一种机器学习管道,使用蛋白质语言模型.
  • 基于与已知临床成功的抗体相似性的聚类抗体序列.

主要成果:

  • 根据序列特征确定了一种预测抗体开发能力的方法.
  • 该管道成功识别了可能具有有利发育能力特征的抗体.
  • 演示了早期选具有较差发育潜力的抗体的策略.

结论:

  • 拟议的管道是选择治疗单克隆抗体候选者的宝贵工具.
  • 这种方法可以显著降低与抗体发现相关的成本和时间.
  • 通过改善早期候选人选择,促进寻求新疗法.